Prof. Whitfield is an internationally recognised leader in precision oncology and molecular diagnostics. His research group has pioneered biomarker-driven trial designs that have shaped modern targeted-therapy pathways. He has authored more than 400 peer-reviewed publications and advises several international consortia on genomics-guided cancer care.